Znaczenie nutrigenomiki w profilaktyce i wspomaganiu leczenia cukrzycy
References
- Aggarwal B.B.: Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Annu. Rev. Nutr., 2010; 30: 173–199
- American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care, 2014; 37: S81–S90
- Babu P.V., Liu D., Gilbert E.R.: Recent advances in understanding the anti-diabetic actions of dietary flavonoids. J. Nutr. Biochem., 2013; 24: 1777–1789
- Cai E.P., Lin J.K.: Epigallocatechin gallate (EGCG) and rutin suppress the glucotoxicity through activating IRS2 and AMPK signaling in rat pancreatic β cells. J. Agric. Food Chem., 2009; 57: 9817–9827
- Carneiro E.M., Latorraca M.Q., Araujo E., Beltrá M., Oliveras M.J., Navarro M., Berná G., Bedoya F.J., Velloso L.A., Soria B., Martin F.: Taurine supplementation modulates glucose homeostasis and islet function. J. Nutr. Biochem., 2009; 20: 503–511
- Castellano J.M., Guinda A., Delgado T., Rada M., Cayuela J.A.: Biochemical basis of the antidiabetic activity of oleanolic acid and related pentacyclic triterpenes. Diabetes, 2013; 62: 1791–1799
- Castro M.C., Francini F., Gagliardino J.J., Massa M.L.: Lipoic acid prevents fructose-induced changes in liver carbohydrate metabolism: Role of oxidative stress. Biochim. Biophys. Acta, 2014; 1840: 1145–1151
- Cobianchi L., Fornoni A., Pileggi A., Molano R.D., Sanabria N.Y., Gonzalez-Quintana J., Bocca N., Marzorati S., Zahr E., Hogan A.R., Ricordi C., Inverardi L.: Riboflavin inhibits IL-6 expression and p38 activation in islet cells. Cell Transplant., 2008; 17: 559–566
- Corless M., Kiely A., McClenaghan N.H., Flatt P.R., Newsholme P.: Glutamine regulates expression of key transcription factor, signal transduction, metabolic gene, and protein expression in a clonal pancreatic β-cell line. J. Endocrinol., 2006; 190: 719–727
- Definicja, rozpoznawanie i klasyfikacja cukrzycy Raport Grupy Konsultacyjnej WHO (1999). Medycyna Praktyczna 2000/01. https://www.mp.pl/artykuly/1161,definicja-rozpoznawanie-i-klasyfikacjacukrzycyraport-grupy-konsultacyjnej-who-1999 (18.04.2020)
- Diaz-Gerevini G.T., Repossi G., Dain A., Tarres M.C., Das U.N., Eynard A.R.: Beneficial action of resveratrol: How and why? Nutrition, 2016; 32: 174–178
- Dong H., Wang N., Zhao L., Lu F.: Berberine in the treatment of type 2 diabetes mellitus: A systemic review and meta-analysis. Evid. Based Complement. Alternat. Med., 2012; 2012: 591654
- Fenech M., El-Sohemy A., Cahill L., Ferguson L.R., French T.A.C., Tai E.S., Milner J., Koh W.P., Xie L., Zucker M., Buckley M., Cosgrove L., Lockett T., Fung K.Y., Head R.: Nutrigenetics and nutrigenomics: Viewpoints on the current status and applications in nutrition research and practice. J. Nutrigenet. Nutrigenomics, 2011; 4: 69–89
- Fowler M.J.: Leczenie cukrzycy: Doustne leki przeciwcukrzycowe. Diabetol. Dypl., 2010; 7: 30–33
- Fu Z., Zhang W., Zhen W., Lum H., Nadler J., Bassaganya-Riera J., Jia Z., Wang Y., Misra H., Liu D.: Genistein induces pancreatic β-cell proliferation through activation of multiple signaling pathways and prevents insulin-deficient diabetes in mice. Endocrinology, 2010; 151: 3026–3037
- Gijsbers L., Ding E.L., Malik V.S., de Goede J., Geleijnse J.M., Soedamah-Muthu S.S.: Consumption of dairy foods and diabetes incidence: A dose-response meta-analysis of observational studies. Am. J. Clin. Nutr. 2016; 103: 1111–1124
- GUS. Infografika – Światowy Dzień Walki z Cukrzycą (14 listopada). https://stat.gov.pl/download/gfx/portalinformacyjny/pl/defaultaktualnosci/5866/46/3/1/cukrzyca_2018-01.jpg (15.04.2020)
- Hagman D.K., Hays L.B., Parazzoli S.D., Poitout V.: Palmitate inhibits insulin gene expression by altering PDX-1 nuclear localization and reducing MafA expression in isolated rat islets of Langerhans. J. Biol. Chem., 2005; 280: 32413–32418
- Hall E., Dayeh T., Kirkpatrick C.L., Wollheim C.B., Dekker Nitert M., Ling C.: DNA methylation of the glucagon-like peptide 1 receptor (GLP1R) in human pancreatic islets. BMC Med. Genet., 2013; 14: 76
- Hindorff L.A., MacArthur J., Morales J., Junkins H.A., Hall P.N., Klemm A.K., Manolio T.A.: A Catalog of Published Genome-Wide Association Studies. http://www.genome.gov/gwastudies (20.04.2020)
- Kobori M., Masumoto S., Akimoto Y., Takahashi Y.: Dietary quercetin alleviates diabetic symptoms and reduces streptozotocin-induced disturbance of hepatic gene expression in mice. Mol. Nutr. Food Res., 2009; 53: 859–868
- Kozek E.: Insulin resistance and hyperinsulinemia – clinical aspects. Przegl. Lek., 1996; 53: 647–652
- Lazo de la Vega-Monroy M.L., Larrieta E., German M.S., Baez-Saldana A., Fernandez-Mejia C.: Effects of biotin supplementation in the diet on insulin secretion, islet gene expression, glucose homeostasis and beta-cell proportion. J. Nutr. Biochem., 2013; 24: 169–177
- Lewicki S., Lewicka A., Kalicki B., Sobolewska-Ruta A., Debski B., Zdanowski R., Syryło T., Kloc M., Kubiak J.Z.: Effects of genistein on insulin pathway-related genes in mouse differentiated myoblast C2C12 cell line: Evidence for two independent modes of action. Folia Histochem. Cytobiol., 2018; 56: 123–132
- Lovis P., Roggli E., Laybutt D.R., Gattesco S., Yang J.Y., Widmann C., Abderrahmani A., Regazzi R.: Alterations in microRNA expression contribute to fatty acid-induced pancreatic β-cell dysfunction. Diabetes, 2008; 57: 2728–2736
- Mancini A., Imperlini E., Nigro E., Montagnese C., Daniele A., Orrù S., Buono P.: Biological and nutritional properties of palm oil and palmitic acid: Effects on health. Molecules, 2015; 20: 17339–17361
- Miller R.G., Secrest A.M., Sharma R.K., Songer T.J., Orchard T.J.: Improvements in the life expectancy of type 1 diabetes: The Pittsburgh Epidemiology of Diabetes Complications study cohort. Diabetes, 2012; 61: 2987–2992
- Mosley A.L., Corbett J.A., Ozcan S.: Glucose regulation of insulin gene expression requires the recruitment of p300 by the β-cell-specific transcription factor Pdx-1. Mol. Endocrinol., 2004; 18: 2279–2290
- Patrick C., Wang G.S., Lefebvre D.E., Crookshank J.A., Sonier B., Eberhard C., Mojibian M., Kennedy C.R., Brooks S.P., Kalmokoff M.L., Maglio M., Troncone R., Poussier P., Scott F.W.: Promotion of autoimmune diabetes by cereal diet in the presence or absence of microbes associated with gut immune activation, regulatory imbalance, and altered cathelicidin antimicrobial peptide. Diabetes, 2013; 62: 2036–2047
- Phillips C.M.: Nutrigenetics and metabolic disease: Current status and implications for personalised nutrition. Nutrients, 2013; 5: 32–57
- Poitout V., Hagman D., Stein R., Artner I., Robertson R.P., Harmon J.S.: Regulation of the insulin gene by glucose and fatty acids. J. Nutr., 2006; 136: 873–876
- Poitout V., Robertson R.P.: Glucolipotoxicity: Fuel excess and β-cell dysfunction. Endocr. Rev., 2008; 29: 351–366
- Qiu L.; List E.O.; Kopchick J.J.: Differentially expressed proteins in the pancreas of diet-induced diabetic mice. Mol. Cell. Proteomics, 2005; 4: 1311–1318
- Rojas A., Carrasco M., Delgado I., Cobo N., Tejedo J.R., Bedoya F.J., Gauthier B., Soria B., Martín F.: Signaling pathways and transcription factors involved in pancreatic islet development. In: Islam S., editor. Adv. Exp. Med. Biol.: The Islets of Langerhans 2. Springer; Berlin, Germany, 2014; 109–128
- Różańska D., Regulska-Ilow A.: The significance of anthocyanins in the prevention and treatment of type 2 diabetes. Adv. Clin. Exp. Med., 2018; 27: 135–142
- Sakaguchi S., Ono M., Setoguchi R., Yagi H., Hori S., Fehervari Z., Shimizu J., Takahashi T., Nomura T.: Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev., 2006; 212: 8–27
- Sales N.M., Pelegrini P.B., Goersch M.C.: Nutrigenomics: Definitions and advances of this new science. J. Nutr. Metab., 2014; 2014: 202759
- Salmond R.J., Filby A., Qureshi I., Caserta S., Zamoyska R.: T-cell receptor proximal signaling via the Src-family kinases, Lck and Fyn, influences T-cell activation, differentiation, and tolerance. Immunol. Rev., 2009; 228: 9–22
- Sommese L., Zullo A., Mancini F.P., Fabbricini R., Soricelli A., Napoli C.: Clinical relevance of epigenetics in the onset and management of type 2 diabetes mellitus. Epigenetics, 2017; 12: 401–415
- Temelkova-Kurktschiev T., Stefanov T.: Life style and genetics in obesity and type 2 diabetes. Exp. Clin. Endocrinol. Diabetes, 2012; 120: 1–6
- Udupa A., Nahar P., Shah S., Kshirsagar M., Ghongane B.: A comparative study of effects of omega-3 fatty acids, alpha lipoic acid and vitamin E in type 2 diabetes mellitus. Ann. Med. Health Sci. Res., 2013; 3: 442–446
- Vallianou N.G., Evangelopoulos A., Kazazis C.: Resveratrol and diabetes. Rev. Diabet. Stud., 2013; 10: 236–242
- Wedick N.M., Pan A., Cassidy A., Rimm E.B., Sampson L., Rosner B., Willett W., Hu F.B., Sun Q., van Dam R.M.: Dietary flavonoid intakes and risk of type 2 diabetes in US men and women. Am. J. Clin. Nutr., 2012; 95: 925–933
- Witkowski M., Tabaraie T., Steffens D., Friebel J., Dörner A., Skurk C., Witkowski M., Stratmann B., Tschoepe D., Landmesser U., Rauch U.: MicroRNA-19a contributes to the epigenetic regulation of tissue factor in diabetes. Cardiovasc. Diabetol., 2018; 17: 34
- Wolden-Kirk H., Rondas D., Bugliani M., Korf H., Van Lommel L., Brusgaard K., Christesen H.T., Schuit F., Proost P., Masini M., Marchetti P., Eizirik D.L., Overbergh L., Mathieu C.: Discovery of molecular pathways mediating 1,25-dihydroxyvitamin D3 protection against cytokine-induced inflammation and damage of human and male mouse islets of Langerhans. Endocrinology, 2014; 155: 736–747
- World Health Organisation: Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia: Report of a WHO/IDF Consultation. Geneva, Switzerland, World Health Organisation, 2006. https://www.who.int/diabetes/publications/diagnosis_diabetes2006/en/ (15.04.2020)
- World Health Organization: Global Report on Diabetes. Geneva 2016. https://apps.who.int/iris/bitstream/handle/10665/204871/9789241565257_eng.pdf (15.04.2020)
- Xu G., Kwon G., Cruz W.S., Marshall C.A., McDaniel M.L.: Metabolic regulation by leucine of translation initiation through the mTOR signaling pathway by pancreatic β-cells. Diabetes, 2001; 50: 353–360
- Yang B.T., Dayeh T.A., Kirkpatrick C.L., Taneera J., Kumar R., Groop L., Wollheim C.B., Nitert M.D., Ling C.: Insulin promoter DNA methylation correlates negatively with insulin gene expression and positively with HbA(1c) levels in human pancreatic islets. Diabetologia, 2011; 54: 360–367
- Yang B.T., Dayeh T.A., Volkov P.A., Kirkpatrick C.L., Malmgren S., Jing X., Renström E., Wollheim C.B., Nitert M.D., Ling C.: Increased DNA methylation and decreased expression of PDX-1 in pancreatic islets from patients with type 2 diabetes. Mol. Endocrinol., 2012; 26: 1203–1212
- Ye D.Z., Tai M.H., Linning K.D., Szabo C., Olson L.K.: MafA expression and insulin promoter activity are induced by nicotinamide and related compounds in INS-1 pancreatic β-cells. Diabetes, 2006; 55: 742–750
- Yu C., Chen Y., Cline G.W., Zhang D., Zong H., Wang Y., Bergeron R., Kim J.K., Cushman S.W., Cooney G.J., Atcheson B., White M.F., Kraegen E.W., Shulman G.I.: Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem., 2002; 277: 50230–50236
- Zalecenia PTD: Zalecenia kliniczne dotyczące postępowania u chorych na cukrzycę 2016. Stanowisko Polskiego Towarzystwa Diabetologicznego. Diabetol Klin. 2016; 5: Supl. A
- Zanda M., Onengut-Gumuscu S., Walker N., Shtir C., Gallo D., Wallace C., Smyth D., Todd J.A., Hurles M.E., Plagnol V., Rich S.S.: A genome-wide assessment of the role of untagged copy number variants in type 1 diabetes. PLoS Genet., 2014; 10: e1004367
- Zeitler P., Fu J., Tandon N., Nadeau K., Urakami T., Barrett T., Maahs D.: Type 2 diabetes in the child and adolescent. Pediatr. Diabetes, 2014; 15: 26–46
- Zhang Z., Ding Y., Dai X., Wang J., Li Y.: Epigallocatechin-3-gallate protects pro-inflammatory cytokine induced injuries in insulin-producing cells through the mitochondrial pathway. Eur. J. Pharmacol., 2011; 670: 311–316
- Ziegler A.G., Nepom G.T.: Prediction and pathogenesis in type 1 diabetes. Immunity, 2010; 32: 468–478
DOI: https://doi.org/10.5604/01.3001.0014.7834 | Journal eISSN: 1732-2693
Language: English
Page range: 133 - 142
Submitted on: May 8, 2020
Accepted on: Nov 20, 2020
Published on: Mar 2, 2021
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 times per year
Keywords:
Related subjects:
© 2021 Ewa Syta, Barbara Bobrowska-Korczak, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.